Condition: Intrahepatic Bile Duct Cancer · Intrahepatic Cholangiocarcinoma (Icc) · Intrahepatic Bile Duct Carcinoma · Sponsor: Erasmus Medical Center
The goal of this clinical trial is to learn if additional chemotherapy by means of a chemo pump can prevent return of disease in adult patients with bile duct cancer in the liver that can be treated with surgery. The main questions it aims to answer are: * Does addition of chemotherapy by means of a chemo pump lead to less return of disease within the liver two years after surgery? * Does addition of chemotherapy by means of a chemo pump lead to longer survival of patients? * Does addition of chemotherapy by means of a chemo pump lead to an increase in quality of life? Participants will receive an implanted chemo pump, through which additional chemotherapy will be given to the liver in addition to surgery.
This description comes directly from the study's public registry record.
Bas Groot Koerkamp, MD, PhD · +31(0)107031810 · b.grootkoerkamp@erasmusmc.nl
Thomas C Zwaan, MD · +31(0)621218051 · t.zwaan@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Erasmus Medical Center | Rotterdam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06888063